In addition, authors have reported a reduction of the FoxP3 protein in post-mortem spinal cord of ALS patients with rapid progression, a GATA3 increase in patients with slower progression, suggesting that the decline in FOXP3 levels may be used as a marker for rapid progression. Here, FOXP3 is linked to amyotrophic lateral sclerosis.